Last updated: October 27, 2023
Sponsor: Weill Medical College of Cornell University
Overall Status: Completed
Phase
N/A
Condition
Diabetes And Hypertension
Diabetes Prevention
Diabetes Mellitus, Type 2
Treatment
Carbohydrate-First Meal Sequence
Carbohydrate-Last Meal Sequence
Clinical Study ID
NCT04738799
20-03021613
Ages > 21 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Metformin-treated type 2 diabetes of less than 10 years duration
- Must be on a stable dose of metformin for at least 1 month
- HbA1c ≤8.5 percent
Exclusion
Exclusion Criteria:
- Relevant food allergies
- Oral steroid therapy within 90 days of enrollment
- Anti-diabetic medications other than metformin
- History of bariatric surgery
- Pregnant women
- Any participant deemed unsuitable in the investigator's opinion
Study Design
Total Participants: 20
Treatment Group(s): 2
Primary Treatment: Carbohydrate-First Meal Sequence
Phase:
Study Start date:
April 29, 2021
Estimated Completion Date:
July 03, 2023
Connect with a study center
Weill Cornell Medicine
New York, New York 10021
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.